Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

The substantial augmentation of the radiation sequelae during chemo–radiotherapy with novel drugs masks the real potential of such regimens. In this study we examined whether subcutaneous administration of amifostine can reduce the toxicity of a highly aggressive chemo–radiotherapy scheme with Steal...

Descripción completa

Detalles Bibliográficos
Autores principales: Koukourakis, M I, Romanidis, K, Froudarakis, M, Kyrgias, G, Koukourakis, G V, Retalis, G, Bahlitzanakis, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376133/
https://www.ncbi.nlm.nih.gov/pubmed/12177774
http://dx.doi.org/10.1038/sj.bjc.6600486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376133/
https://www.ncbi.nlm.nih.gov/pubmed/12177774
http://dx.doi.org/10.1038/sj.bjc.6600486

Ejemplares similares